4-[8-amino-3-[1-[4-[[3-[(prop-2-enoylamino)methyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-8-yl]amino]but-2-ynoyl]piperidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methyl-N-pyridin-2-ylbenzamide
C50H44N14O4 — CID 123546043
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[8-amino-3-[1-[4-[[3-[(prop-2-enoylamino)methyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-8-yl]amino]but-2-ynoyl]piperidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methyl-N-pyridin-2-ylbenzamide
4-[8-amino-3-[1-[4-[[3-[(prop-2-enoylamino)methyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-8-yl]amino]but-2-ynoyl]piperidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methyl-N-pyridin-2-ylbenzamide (PubChem CID 123546043) has the molecular formula C50H44N14O4 and a molecular weight of 905.00 g/mol. Its IUPAC name is 4-[8-amino-3-[1-[4-[[3-[(prop-2-enoylamino)methyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-8-yl]amino]but-2-ynoyl]piperidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methyl-N-pyridin-2-ylbenzamide.
Molecular Properties
| Compound Name | 4-[8-amino-3-[1-[4-[[3-[(prop-2-enoylamino)methyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-8-yl]amino]but-2-ynoyl]piperidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methyl-N-pyridin-2-ylbenzamide |
|---|---|
| PubChem CID | 123546043 |
| Molecular Formula | C50H44N14O4 |
| Molecular Weight | 905.00 g/mol |
| Exact Mass | 904.37 |
| IUPAC Name | 4-[8-amino-3-[1-[4-[[3-[(prop-2-enoylamino)methyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-8-yl]amino]but-2-ynoyl]piperidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methyl-N-pyridin-2-ylbenzamide |
| SMILES | C=CC(=O)NCc1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(NCC#CC(=O)N3CCCCC3c3nc(-c4ccc(C(=O)Nc5ccccn5)cc4C)c4c(N)nccn34)nccn12 |
| InChI | InChI=1S/C50H44N14O4/c1-3-40(65)57-30-39-60-42(32-15-17-33(18-16-32)49(67)58-37-12-4-7-21-52-37)45-47(56-25-27-63(39)45)55-23-10-14-41(66)62-26-9-6-11-36(62)48-61-43(44-46(51)54-24-28-64(44)48)35-20-19-34(29-31(35)2)50(68)59-38-13-5-8-22-53-38/h3-5,7-8,12-13,15-22,24-25,27-29,36H,1,6,9,11,23,26,30H2,2H3,(H2,51,54)(H,55,56)(H,57,65)(H,52,58,67)(H,53,59,68) |
| InChIKey | FKSLVCXUBIYSRW-UHFFFAOYSA-N |
| XLogP | 6.26 |
| TPSA | 231.82 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 905.00 |
| LogP ≤ 5 | 6.26 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123546043 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.